Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia

Journal of Clinical Investigation

Volumn 100, Issue 12, 1997, Pages 3121-3130

  Mittelman, Steven D ^a   Fu, You Yin ^a   Rebrin, Kerstin ^b   Steil, Garry ^c   Bergman, Richard N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b MiniMed Inc   (United States)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

Free fatty acids; Liver; Metabolism; NIDDM; Turnover

Indexed keywords

FATTY ACID; GLUCAGON; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HYPERGLUCAGONEMIA; HYPERGLYCEMIA; HYPERINSULINEMIA; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL;

EID: 0031467268     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119867     Document Type: Article

References (51)

1. Claus, T.H., and S.J. Pilkis. 1976. Regulation by insulin of gluconeogenesis in isolated rat hepatocytes. Biochim. Biophys. Acta. 421:246-262.
2. Mackrell, D.J., and J.E. Sokal. 1969. Antagonism between the effects of insulin and glucagon on the isolated liver. Diabetes. 18:724-732.
3. Madison, L. L., B. Combes, W. Strickland, R. Unger, and R. Adams. 1959. Symposium on the hypoglycemic agents: evidence for a direct effect of insulin on hepatic glucose output. Metab. Clin. Exp. 8:469-471.
4. Ader, M., and R.N. Bergman. 1990. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am. J. Physiol 258: E1020-E1032.
5. Rebrin, K., G.M. Steil, L. Getty, and R.N. Bergman. 1995. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes. 44:1038-1045.
6. Rebrin, K., G.M. Steil, S.D. Mittelman, and R.N. Bergman. 1996. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J. Clin. Invest. 98:741-749.
7. Ishida, T., Z. Chap, J. Chou, R.M. Lewis, C.J. Hartley, M.L. Entman, and J.B. Field. 1984. Effects of portal and peripheral venous insulin infusion on glucose production and utilization in depancreatized, conscious dogs. Diabetes. 33: 984-990.
8. Prager, R., P. Wallace, and J.M. Olefsky. 1987. Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes. 36:607-611.
9. Giacca, A., S.J. Fisher, Z.Q. Shi, R. Gupta, H. Lavina, A. Lickley, and M. Vranic. 1992. Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J. Clin. Invest. 90:1769-1777.
10. Lewis, G.F., B. Zinman, Y. Groenewoud, M. Vranic, and A. Giacca. 1996. Hepatic glucose production is regulated both by direct hepatic and extra hepatic effects of insulin in humans. Diabetes. 45:454-462.
11. Cersosimo, E., R.L. Judd, and J.M. Miles. 1994. Insulin regulation of renal glucose metabolism in conscious dogs. J. Clin. Invest. 93:2584-2589.
12. Glinsmann, W.H., and G.E. Mortimore. 1968. Influence of glucagon and 3′, 5′-AMP on insulin responsiveness of the perfused rat liver. Am. J. Physiol. 215:553-559.
13. Yu, B., S. Pugazhenthi, and R.L. Khandelwal. 1994. Effects of metformin on glucose and glucagon regulated gluconeogenesis in cultured normal and diabetic hepatocytes. Biochem. Pharmacol. 48:949-954.
14. Cherrington, A.D., W.W. Lacy, P.E. Williams, and K.E. Steiner. 1983. Failure of somatostatin to modify effect of glucagon on carbohydrate metabolism in the dog. Am. J. Physiol. 244:E596-E602.
15. Stevenson, R.W., J.A. Parsons, and K.G.M.M. Alberti. 1983. Effect of intraportal and peripheral insulin on glucose turnover and recycling in diabetic dogs. Am. J. Physiol. 244:E190-E195.
16. Griffen, S.C., S.M. Russell, L.S. Katz, and C.S. Nicoll. 1987. Insulin exerts metabolic and growth-promoting effects by a direct action on the liver in vivo: clarification of the functional significance of the portal vascular link between the beta cells of the pancreatic islels and the liver. Proc. Natl. Acad. Sci. USA. 84:7300-7304.
17. Sindelar, D.K., C.A. Chu, A. Venkatakrishnan, P. Venson, and A.D. Cherrington. 1996. The interaction between increments in peripheral and portal vein insulin in regulating hepatic glucose production. Diabetes. 45:167a. (Abstr.)
18. Sindelar, D.K., J.H. Balcom, C.A. Chu, D.W. Neal, and A.D. Cherrington. 1996. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes. 45: 1594-1604.
19. Polonsky, K., J. Jaspan, D. Emmanouel, K. Holmes, and A.R. Moossa. 1983. Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism. Acta Endocrinol. 102: 420-427.
20. Lewis, G.F., M. Vranic, and A. Giacca. 1997. Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans. Am. J. Physiol. 272:E371-E378.
21. Giacca, A., S.J. Fisher, R.H. McCall, Z.Q. Shi, and M. Vranic. 1997. Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon. Endocrinology. 138:999-1007.
22. Bergman, R.N., M. Ader, D.T. Finegood, and G. Pacini. 1984. Extrapancreatic effect of somatostatin infusion to increase glucose clearance. Am. J. Physiol. 247:E370-E379.
23. Finegood, D.T., R.N. Bergman, and M. Vranic. 1987. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusates. Diabetes. 36:914-924.
24. Zambon, A., S.I. Hashimoto, and J.D. Brunzell. 1993. Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J. Lipid Res. 34:1021-1028.
25. Katz, J., F. Okajima, M. Chenoweth, and A. Dunn. 1981. The determination of lactate turnover in vivo with 3H and 14C-labeled lactate: the significance of sites of tracer administration and sampling. Biochem. J. 194:513-524.
26. Greenway, C.V., and R.D. Stark. 1971. Hepatic vascular bed. Physiol. Rev. 51:23-65.
27. Hother-Nielsen, O., J.E. Henriksen, P. Staehr, and H. Beck-Nielsen. 1995. Labeled glucose infusate technique in clamp studies. Is precise matching of glucose specific activity important? Endocrinol. Metab. 2:275-287.
28. Fisher, S.J., Z.Q. Shi, L.A. Lickley, S. Efendic, M. Vranic, and A. Giacca. 1996. A moderate decline in specific activity does not lead to an underestimation of hepatic glucose production during a glucose clamp. Metab. Clin. Exp. 45:587-593.
29. Cherrington, A.D., P.E. Williams, G.I. Shulman, and W.W. Lacy. 1981. Differential time course of glucagon's effect on glycogenolysis and gluconeogenesis in the conscious dog. Diabetes. 30:180-187.
30. Bradley, D.C. and R.N. Bergman. 1992. Hepatic glucagon sensitivity and fasting glucose concentration in normal dogs. Am. J. Physiol. 262:E539-E545.
31. Magnusson, I., D.L. Rothman, D.P. Gerard, L.D. Katz, and G.I. Shulman. 1995. Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration. Diabetes. 44:185-189.
32. Levine, R., and I.B. Fritz. 1956. The relation of insulin to liver metabolism. Diabetes. 5:209-219.
33. Marliss, E.B., T.T. Aoki, R.H. Unger, J.S. Soeldner, and G.F.J. Cahill. 1970. Glucagon levels and metabolic effects in fasting man. J. Clin. Invest. 49: 2256-2270.
34. Baron, A.D., L. Schaeffer, P. Shragg, and O.G. Kolterman. 1987. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes. 36:274-283.
35. Lefebvre, P.J., and A.S. Luyckx. 1979. Glucagon and diabetes: a reappraisal. Diabetologia. 16:347-354.
36. Gerich, J.E. 1977. On the causes and consequences of abnormal glucagon secretion in human diabetes mellitus. In Glucagon: Its Role in Physiology and Clinical Medicine. P.P. Foa, J.S. Bajaj, and N.L. Foa, editors. Springer-Verlag. New York. 617-641.
37. Sánchez-Gutiérrez, J.C., J.A. Sánchez-Arias, C.G. Lechuga, J.C. Valle, B. Samper, and J.E. Feliu. 1994. Decreased responsiveness of basal gluconeogenesis to insulin action in hepatocytes isolated from genetically obese (fa/fa) Zucker rats. Endocrinology. 134:1868-1873.
38. Williamson, J.R., A. Garcia, A.E. Renold, and G.F.J. Cahill. 1966. Studies on the perfused rat liver I: effects of glucagon and insulin on glucose metabolism. Diabetes. 15:183-187.
39. Rizza, R.A., R.E. Westland, L.D. Hall, G.S. Patton, M.W. Haymond, A.H. Clemens, J.E. Gerich, and F.J. Service. 1981. Effect of peripheral versus portal venous administration of insulin on postprandial hyperglycemia and glucose turnover in alloxan-diabetic dogs. Mayo Clin. Proc. 56:434-438.
40. Hother-Nielsen, O., A. Mengel, J. Moller, O. Rasmusscn, O. Schmitz, and H. Beck-Nielsen. 1992. Assessment of glucose turnover rates in euglycemic clamp studies using primed-constant [3-3H] glucose infusion and labeled or unlabeled glucose infusates. Diabetic Med. 9:840-849.
41. Greenway, C.V., and G. Oshiro. 1972. Intrahepatic distribution of portal and hepatic arterial blood flows in anaesthetized cats and dogs and the effects of portal occlusion, raised venous pressure and histamine. J. Physiol. 227:473-485.
42. Stumvoll, M., U. Chintalapudi, G. Perriello, S. Welle, O. Gutierrez, and J.E. Gerich. 1995. Uptake and release of glucose by the human kidney: postabsorptive rates and responses to epinephrine. J. Clin. Invest. 96:2528-2533.
43. Pak, J.M., and S.S. Lee. 1994. Glucagon in portal hypertension. J. Hepatol. 20:825-832.
44. Borghi, V.C., B.L. Wajchenberg, and R.H. Albuquerque. 1984. Evaluation of a sensitive and specific radioimmunoassay for pancreatic glucagon in human plasma and its clinical application. Clin. Chim. Acta. 136:39-48.
45. Bradley, D.C., and R.N. Bergman. 1992. Restoration of stable metabolic conditions during islet suppression in dogs. Am. J. Physiol. 262:E532-E538.
46. Gabbay, R.A., and H.A. Lardy. 1984. Site of insulin inhibition of cAMP-stimulated glycogenolysis: cAMP-dependent protein kinase is affected independent of CAMP changes. J. Biol. Chem. 259:6052-6055.
47. Boyd, M.E., E.B. Albright, D.W. Foster, and J.D. McGarry. 1981. In vitro reversal of the fasting state of liver metabolism in the rat. J. Clin. Invest. 68:142-152.
48. lynedjian, P.B., S. Marie, A. Gjinovci, B. Genin, S.P. Deng, L. Buhler, P. Morel, and G. Mentha. 1995. Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocyles. J. Clin. Invest. 95:1966-1973.
49. Sindelar, D.K., C.A. Chu, M. Rohlie, D.W. Neal, L.L. Swift, and A.D. Cherrington. 1997. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes. 46:187-196.
50. Morand, C., C. Remesy, and C. Demigne. 1993. Fatty acids are potent modulators of lactate utilization in isolated hepatocytes from fed rats. Am. J. Physiol. 264:E816-E823.
51. Williamson, J.R., R.A. Kreisberg, and P.W. Felts. 1966. Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc. Natl. Acad. Sci. USA. 56:247-254.